Patterns of immune responses evoked by allogeneic hepatocytes -: Evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection
Patterns of immune responses evoked by allogeneic hepatocytes -: Evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection
复制标题
DOI:
10.1097/00007890-199908270-00019
复制
发表时间:
1999-08-27
期刊:
影响因子:
6.2
通讯作者:
Orosz, CG
中科院分区:
文献类型:
--
作者:
Bumgardner, GL;Li, JS;Orosz, CG
Introduction. This is the first in a series of reports that characterizes immune responses evoked by allogeneic hepatocytes using a functional model of hepatocyte transplantation in mice,Methods, "Donor" hepatocytes expressing the transgene human alpha-1-antitrypsin (kA1AT-FVB/N, H2(q)) were transplanted into C57BL/6 (H2(b)) or MHC II knockout (H2b) hosts treated with anti-CD4, anti-CD8, or a combination of anti-CD4 and anti-CD8 monoclonal antibodies (mAbs), Hepatocyte rejection was determined as a loss of circulating: ELISA-detectable transgene product (hA1AT), In addition, some C57BL/6 mice underwent transplantation with FVB/N heterotopic cardiac allografts and were treated with anti-CD4 mAb, Cardiac allograft rejection was determined by palpation. Craft recipients were tested for donor-reactive alloantibodies and donor-reactive delayed-type hypersensitivity (DTH) responses.Results. The median survival time (MST) of allogeneic hepatocytes in normal C57BL/6 mice was 10 days (no treatment), 10 days (anti-CD4 mAb), 14 days (anti-CD8 mAb), and 35 days (anti-CD4 and anti-CD8 mAbs), The MST of hepatocytes in B6 MHC class II knockout mice was 10 days (no treatment) and 21 days (anti-CD8 mAb), The MST of cardiac allografts was 11 days (no treatment) and >100 days (anti-CD4 mAb). Donor-reactive DTH responses were readily detected in both untreated and mAb-treated recipients. Donor-reactive alloantibody was barely detectable in untreated hosts.Conclusions. These studies demonstrate that allogeneic hepatocytes are highly immunogenic and stimulate strong cell-mediated immune responses by both CD4(+) and CD8(+) T cells, even when treated with agents that can cause acceptance of cardiac allografts, Indeed, CD4(+) or CD8(+) T cells seem to independently cause hepatocellular allograft rejection. Allogeneic hepatocytes evoked strong donor-reactive DTH responses but were poor stimuli for donor-reactive antibody production, This is an unusual pattern of immune reactivity in allograft recipients.